Lobbying

"Fixers" Fail to Keep Mortgage Execs' Parachutes Golden

After taking control of mortgage giants Fannie Mae and Freddie Mac, the U.S.

Chesapeake's Gas-Powered News

Faced with "public complaints about its new drilling in an urban area" -- Fort Worth, Texas -- the natural gas company Chesapeake Energy is about to launch its own "brand-new media source," Shale.tv. The online video channel will be produced by "three Dallas-area former journalists," and is named after the Barnett Shale natural gas formation in North Texas.

Canadian Lobbyists Apply Elbow Grease to U.S. Democrats

"If you don't like the oil sands oil, what companies will do [in Canada] is build a bigger pipeline to the west coast and export it to China and India," warned a lobbyist for Nexen Energy, which has "major investments" in the oil sands region of Alberta, Canada. He was attending the U.S.

Colombia Still Pushing on Trade Agreement

The Colombian government will pay U.S. lobbyist Andrew J. Samet another $45,000, "to present Colombia's track record on labor issues to Congress, non-governmental organizations and labor unions." The new contract is similar to Samet's earlier work to push the U.S.

How the Gun Lobby Beat Activists to the Draw

Readers of the book "Toxic Sludge Is Good for You" may remember the name Mary Lou Sapone -- a corporate spy who, while secretly in the employ of U.S. Surgical, infiltrated animal rights groups.

Whose Line Is It, Anyway?

It's an "open secret of lobbying," writes Jeffrey Birnbaum. "Public relations firms regularly solicit authors of opinion-page articles, draft the pieces for them and place the articles in publications where they will have the most impact -- all for a fee." Recently, an op-ed criticizing a bill that would reduce credit card fees appeared in Southern newspapers, attributed to Charles Steele Jr., the president of the Southern Christian Leadership Conference (SCLC).

Pushing Prescriptions

"Washington's largest lobby, the pharmaceutical industry, racked up another banner year on Capitol Hill in 2007, backed by a record $168 million lobbying effort," reports M. Asif Ismail.

If You Can't Beat 'Em, Hire 'Em

Daniel Troy served as chief counsel for the U.S. Food and Drug Administration from 2001 to 2004. Starting September 2, 2008, he will be head counsel for the pharmaceutical company GlaxoSmithKline.

Syndicate content